Medpace Holdings Inc. MEDP
Super Investor & Insider
3
Fondi che lo detengono
#312
Rank consenso
4.3%
% dei portafogli
$261.6M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Francois Rochon · Giverny Capital | 4.5% | Reduce 2.75% | 256,081 | $123.0M |
| Vulcan Value Partners · Vulcan Value Partners | 2.58% | Buy | 203,068 | $97.5M |
| Mairs & Power · Mairs & Power | 0.42% | Add 28.58% | 85,720 | $41.2M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Medpace Holdings is a global, full-service clinical contract research organization that provides outsourced drug development and clinical trial services to biotechnology, pharmaceutical, and medical device companies. The firm specializes in comprehensive clinical development support across phases I through IV, offering…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees6,300
TickerMEDP
Statistics
Market Cap$13.08B
Revenue (TTM)$2.53B
Net Income$451.1M
Net Margin17.8%
EPS$15.28
P/E29.86
P/S5.07
P/B22.68
EV/EBITDA22.10
ROE77.3%
Dividend Yield—
Price$457.85
Data: Twelve Data · Revenue = mcap / P/S